Charting a Value‑Driven Healthcare Future: BD Saudi Arabia’s GM on Local Impact, Innovation & Vision 2030

Becton, Dickinson and Company (BD), a global leader in medical technology, is advancing its commitment to transforming healthcare in the Kingdom through local manufacturing, cutting‑edge innovation, and alignment with Saudi Vision 2030. In an exclusive conversation, [Name], General Manager of BD Saudi Arabia, outlines BD’s strategy to drive sustainable impact—from empowering local talent to supporting the national healthcare ecosystem.

Aligning with Vision 2030: Localisation & Economic Diversification
“Vision 2030 has reshaped our operating environment,” states the GM. The national push to grow the non‑oil GDP, spur localisation, and foster a knowledge‑based economy resonates deeply with BD’s plans . By localising production and supply chains, BD strengthens Saudi capacity in advanced medical supplies—supporting the Vision’s goal of boosting SME and manufacturing contributions to GDP.

Driving Innovation Through Local Research & Development
BD is scaling investment in local R&D. “We are developing diagnostic tools tailored to the Kingdom—focusing on regional disease patterns and patient needs,” the GM explains. These efforts align with Vision‑driven goals to integrate AI and automation in healthcare, enhancing clinical accuracy and driving system efficiency
sharikatmubasher.com
+1
btireports.com
+1
.

Empowering Saudi Talent: A Workforce for the Future
Human capital stands at the heart of healthcare transformation. “We’re building local expertise—training Saudis in biotech, quality assurance, and medical device manufacturing,” the GM emphasizes. This aligns with Vision 2030’s push to develop human leadership and workforce upskilling, especially in high‑tech sectors . Local hiring has risen sharply, with over 60% of BD’s Riyadh workforce now Saudi nationals, and women occupying one‑third of leadership positions.

Sustainable Supply Chains & Access to Care
BD’s local manufacturing reduces lead times and dependency on imports. “By producing key consumables here—like syringes, catheters, and PCR kits—we ensure faster deployment, lower costs, and stronger supply resilience,” the GM highlights. This supports Vision goals around healthcare access and self‑reliance.

Collaborations, Entrepreneurship & Ecosystem Growth
In partnership with the Ministry of Investment and Saudi hospitals, BD is launching HealthTech Accelerator Programs, backing local startups focusing on telemedicine, AI diagnostics, and supply‑chain logistics. These initiatives create synergies with Vision 2030’s support for SMEs and innovation ecosystems

A Vision for 2030 and Beyond
Looking ahead, BD aims to expand local content to 70% of its marketed consumables, invest SAR 200 million in Saudi R&D by 2030, and train 5,000 Saudi healthcare professionals in advanced diagnostics and device management. “Our commitment is about more than business—it’s about shaping a healthier, empowered Saudi Arabia by 2030.”